Patent · US Active

Peptide-based compounds for use in the prevention, treatment and/or detection of cancer

US12084511B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

Universitätsmedizin der Johannes Gutenberg-Universität Mainz · DE

Inventors

Edgar Schmitt · Mainz, DE
Horst Kunz · Mainz, DE
Natascha Stergiou · Mainz, DE
Nikola Gaidzik · Heidelberg, DE

Key dates

Filing date	Mar 18, 2019
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Jan 9, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/622
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound comprising a first polypeptide sequence comprising at least three different amino acid sequences selected from the group consisting of GFTFSDYW (SEQ ID NO: 1), IRLKSNNYAA (SEQ ID NO: 2) and TFGNSFAY (SEQ ID NO: 3), a second polypeptide sequence comprising at least three different amino acid sequences selected from the group consisting of TGAVTTNNY (SEQ ID NO: 4), GTN (SEQ ID NO: 5) and ALWYSNHWV (SEQ ID NO: 6), or a variant of any one of said amino acid sequences of SEQ ID NO: 1 to SEQ ID NO: 6 having a different amino acid at one position, wherein said compound or variant is capable of binding to tumour-associated Mucin-1 (TA-MUC1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.